Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma.

Zhang Y, Yang Z, Tang Y, Guo C, Lin D, Cheng L, Hu X, Zhang K, Li G

Open source

DOI
10.1016/j.gendis.2022.07.005
Published
2023 Jul
Container
Genes & diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.gendis.2022.07.005,
  title = {Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma.},
  author = {Zhang Y and Yang Z and Tang Y and Guo C and Lin D and Cheng L and Hu X and Zhang K and Li G},
  year = {2023},
  journal = {Genes \& diseases},
  doi = {10.1016/j.gendis.2022.07.005},
  url = {https://doi.org/10.1016/j.gendis.2022.07.005}
}

RIS

TY  - JOUR
TI  - Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma.
AU  - Zhang Y
AU  - Yang Z
AU  - Tang Y
AU  - Guo C
AU  - Lin D
AU  - Cheng L
AU  - Hu X
AU  - Zhang K
AU  - Li G
PY  - 2023
JO  - Genes & diseases
DO  - 10.1016/j.gendis.2022.07.005
UR  - https://doi.org/10.1016/j.gendis.2022.07.005
ER  - 

APA

Y, Z., Z, Y., Y, T., C, G., D, L., L, C., X, H., K, Z., & G, L. (2023). Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma.. Genes & diseases. https://doi.org/10.1016/j.gendis.2022.07.005

Source records